Prof. Ovidiu C. Baltatu Memo

Prof. Ovidiu Constantin Baltatu, MD PhD – Career Summary

Accomplished MD-PhD scientist with extensive experience in academia at Universities in Brazil and Middle East, biotech at Speedel , and pharma at The Medicines Company (MDC), and consultant for biotech and pharma. A dedicated researcher and educator with a focus on translating scientific discoveries into impactful clinical applications.

Additional Roles

  • Founding Member, Biotechnology Advisory Board, Technology Park of São José dos Campos, Brazil: Contributed to fostering collaborations and attracting investment.
  • Editorial Board Member: Frontiers in Translational Medicine, Frontiers in Integrative Physiology,Discover Medicine (Springer).

Proven Track Record

  • Scientific Leadership: Led a research team that identified new biomarkers, the translational R&D for the first direct renin inhibitor (Aliskiren).
  • Regulatory Affairs: Served as an expert evaluator for the ANVISA (Brazil), member of the Abu Dhabi Health, Research and Technology Council (ADHRTC) (UAE).
  • Cross-functional Collaboration: Successfully bridged academia, industry, and government sectors to secure funding and execute collaborative research projects focused on biotechnology digital health.

Key Achievements

  • Impactful Research: 10,000+ citations (Google Scholar, H-index: 41; i10-index: 75) for research primarily focused on the intersection of cardiovascular, renal, and metabolic systems.
  • Mentorship: Guided 30+ theses and dissertations, with many mentees going on to successful careers in medicine, health and engineering.
  • Leadership: Led a cross-functional teams in multicultural environments in Europe, Americas and Middle East.
  • Academic-Industry Collaborations: 

Specialties

  • Cardiovascular-Renal and Metabolic Research
  • Medical Physiology & Pharmacology
  • Digital transformation and big data in healthcare

Vision

Passionate about leveraging innovative technologies to advance diagnostics, therapeutics, and disease prevention strategies, with a focus on developing personalized medicine approaches for noncommunicable diseases (NCDs), including cardiovascular, renal and metabolic diseases.

Scientific Publications